← Back to Search

Diagnostic Test

Influenza A infection for COVID-19 (STARFISH Trial)

N/A
Waitlist Available
Research Sponsored by Thermo Fisher Scientific, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between february 2023 and april 2024
Awards & highlights

Summary

This is a non-interventional study to perform the clinical performance evaluation of the Starfish Test using prospectively collected matched nasopharyngeal and nasal swab samples from the same donor.

Eligible Conditions
  • COVID-19
  • Respiratory Syncytial Virus
  • Flu Type B
  • Flu

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between february 2023 and april 2024
This trial's timeline: 3 weeks for screening, Varies for treatment, and between february 2023 and april 2024 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Endpoint
Secondary outcome measures
Secondary Endpoint

Trial Design

4Treatment groups
Experimental Treatment
Group I: SARS-CoV-2 infectionExperimental Treatment1 Intervention
50 positive samples 500 negative samples
Group II: RSV infectionExperimental Treatment1 Intervention
30 positive samples 500 negative samples
Group III: Influenza B infectionExperimental Treatment1 Intervention
30 positive samples 500 negative samples
Group IV: Influenza A infectionExperimental Treatment1 Intervention
50 positive samples 500 negative samples
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
The Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel
2023
N/A
~1910

Find a Location

Who is running the clinical trial?

NAMSAOTHER
46 Previous Clinical Trials
16,923 Total Patients Enrolled
1 Trials studying COVID-19
41 Patients Enrolled for COVID-19
Thermo Fisher Scientific, IncLead Sponsor
23 Previous Clinical Trials
19,282 Total Patients Enrolled
1 Trials studying COVID-19
1,076 Patients Enrolled for COVID-19
~764 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top